atenolol has been researched along with cardiovascular agents in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 14 (48.28) | 29.6817 |
| 2010's | 5 (17.24) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Partanen, J; Pellinen, TJ | 1 |
| Sanchez-Cascos, A | 1 |
| Heusch, G; Rose, J; Schulz, R; Skyschally, A | 1 |
| Bretnall, AE; Clarke, GS | 1 |
| Johnson, IR; Rouse, W | 1 |
| Brzostek, T; Collen, D; Heidbüchel, H; Janssens, L; Lesaffre, E; Mortelmans, L; Scheys, I; Van de Werf, F; Wackers, FJ; Willems, GM | 1 |
| Chierchia, SL; Fragasso, G; Margonato, A; Rossetti, E; Xuereb, M; Xuereb, RG | 1 |
| Chen, IJ; Chiang, LC; Chiu, CC; Liang, JC; Lin, YT; Tsai, CH; Wu, JR; Yeh, JL | 1 |
| Beckerman, B; Brennan, C; Bultas, J; Deanfield, JE; Detry, JM; Lichtlen, PR; Sellier, P; Thaulow, E; Young, ST | 1 |
| Mamchur, SE; Sankevitch, TV; Stepatcheva, TA; Teplyakov, AT | 1 |
| Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA | 1 |
| Gratsianskiĭ, NA | 1 |
| Bourassa, MG; Ford, I; Fox, K; Tardif, JC; Tendera, M | 1 |
| Berdeaux, A; Bizé, A; Colin, P; Ghaleh, B; Lucats, L; Monnet, X | 1 |
| Dahlöf, B; Devereux, RB | 1 |
| Kumar, V; Shah, RP; Singh, S | 1 |
| Kumar, V; Malik, S; Singh, S | 1 |
| Afzal, R; Pais, P; Pogue, J; Sigamani, A; Xavier, D; Yusuf, S | 1 |
| Kahan, T; Ponikowski, P; Tardif, JC | 1 |
| Bando, T; Chen, F; Fujinaga, T; Hanaoka, N; Hasegawa, S; Sakai, H; Shoji, T | 1 |
| Sajadieh, A | 1 |
| Alonso, RM; Ferreirós, N; Gonzalez, O; Iriarte, G; Jiménez, RM; Maguregui, MI; Rico, E | 1 |
| Guarve, K; Gupta, GD | 1 |
| Bonagura, JD; Cervenec, RM; Riesen, SC; Schober, KE | 1 |
| Beutler, D; Bosak, A; Graeme, K; Heise, CW; Loli, A; Orme, G | 1 |
| Hasanzadeh, M; Niaei, N; Shadjou, N | 1 |
| Liang, J; Meng, H; Zhang, K; Zhao, Y; Zheng, X | 1 |
| Gao, Z; Lin, H; Lin, W; Liu, A; Ping, S; Ren, Y | 1 |
| Dunford, L; Lawson, G; Ogwu, J; Tanna, S; Wata, D | 1 |
1 review(s) available for atenolol and cardiovascular agents
| Article | Year |
|---|---|
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiovascular Agents; Cohort Studies; Drug Utilization; Endothelium, Vascular; Follow-Up Studies; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Models, Biological; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Precursors; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Stroke; Thrombosis; Treatment Outcome | 2007 |
8 trial(s) available for atenolol and cardiovascular agents
| Article | Year |
|---|---|
Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atenolol; Cardiovascular Agents; Clonidine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency; Ventricular Function, Left | 1993 |
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide; Male; Middle Aged; Myocardial Ischemia | 2002 |
[The use of fatty acid beta-oxidation inhibitor mildronate as monotherapy or in combination with atenolol in patients with left ventricular dysfunction after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Agents; Drug Therapy, Combination; Humans; Male; Methylhydrazines; Middle Aged; Mitochondrial Trifunctional Protein; Multienzyme Complexes; Myocardial Infarction; Ventricular Dysfunction, Left | 2003 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis | 2004 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Heart Conduction System; Humans; Ion Channels; Ivabradine; Male; Middle Aged | 2005 |
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atenolol; Capsules; Cardiovascular Agents; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Combinations; Drug Costs; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Platelet Aggregation Inhibitors; Primary Prevention; Ramipril; Research Design; Secondary Prevention; Simvastatin; Treatment Outcome | 2009 |
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ion Channels; Ivabradine; Male; Middle Aged; Sinoatrial Node; Treatment Outcome; Young Adult | 2009 |
Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats.
Topics: Animals; Atenolol; Atrial Function, Left; Benzazepines; Cardiovascular Agents; Cats; Double-Blind Method; Echocardiography; Female; Heart Atria; Heart Rate; Heart Ventricles; Ivabradine; Reproducibility of Results; Ventricular Function, Left | 2012 |
20 other study(ies) available for atenolol and cardiovascular agents
| Article | Year |
|---|---|
Diltiazem and sinus arrest in connection with atenolol and digoxin.
Topics: Atenolol; Cardiovascular Agents; Drug Administration Schedule; Drug Therapy, Combination; Heart Arrest; Humans; Male; Middle Aged | 1989 |
Evaluation of effect of drugs on the exercise ECG.
Topics: Atenolol; Blood Pressure; Cardiovascular Agents; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Propranolol; Verapamil | 1981 |
Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
Topics: Adenosine Triphosphate; Animals; Atenolol; Benzazepines; Blood Pressure; Bradycardia; Cardiovascular Agents; Coronary Circulation; Disease Models, Animal; Female; Heart; Heart Rate; Injections, Intravenous; Lactates; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Oxygen Consumption; Phosphocreatine; Reperfusion Injury; Swine; Swine, Miniature | 1995 |
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil | 1995 |
Haemodynamic actions of a novel sino-atrial node function modulator, ZENECA ZD7288, in the anaesthetized dog: a comparison with zatebradine, atenolol and nitrendipine.
Topics: Animals; Atenolol; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dogs; Heart Rate; Hemodynamics; Nitrendipine; Pyrimidines; Sinoatrial Node | 1994 |
Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Atenolol; Cardiovascular Agents; Coronary Disease; Data Interpretation, Statistical; Diastole; Diltiazem; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Follow-Up Studies; Humans; Middle Aged; Nifedipine; Nitrates; Stroke Volume; Systole; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1999 |
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Benzaldehydes; Blood Pressure; Cardiovascular Agents; Depression, Chemical; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Heart Rate; Isoproterenol; Labetalol; Mecamylamine; Models, Animal; Muscle, Smooth, Vascular; Myocardial Contraction; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Regression Analysis; Stimulation, Chemical; Vasodilator Agents | 2000 |
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Exercise Test; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Time Factors; Vasodilator Agents | 2004 |
Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzazepines; Cardiovascular Agents; Dogs; Heart Rate; Heart Ventricles; Ivabradine; Myocardium; Physical Conditioning, Animal | 2007 |
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products.
Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization | 2008 |
Polypill for the treatment of cardiovascular diseases part 2. LC-MS/TOF characterization of interaction/degradation products of atenolol/lisinopril and aspirin, and mechanisms of formation thereof.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atenolol; Cardiovascular Agents; Chromatography, Liquid; Drug Combinations; Drug Interactions; Lisinopril; Mass Spectrometry; Molecular Structure; Molecular Weight; Platelet Aggregation Inhibitors | 2008 |
Right ventricular outflow tract obstruction after bilateral lung transplantation.
Topics: Adult; Atenolol; Cardiac Surgical Procedures; Cardiovascular Agents; Disopyramide; Drug Therapy, Combination; Female; Heart Septal Defects, Atrial; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Transplantation; Radiography; Treatment Outcome; Ventricular Outflow Obstruction | 2009 |
A new combination therapy in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Humans; Ivabradine; Treatment Outcome | 2009 |
LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma.
Topics: Ammonium Sulfate; Atenolol; Bisoprolol; Cardiovascular Agents; Chromatography, Liquid; Drug Stability; Formates; Humans; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
Formulation and evaluation of extended release asymmetric membrane capsules of atenolol.
Topics: Atenolol; Capsules; Cardiovascular Agents; Cellulose; Citric Acid; Delayed-Action Preparations; Diffusion; Drug Compounding; Drug Delivery Systems; Excipients; Hydrogen-Ion Concentration; Hypromellose Derivatives; Kinetics; Mannitol; Methylcellulose; Microscopy, Electron, Scanning; Solubility; Surface Properties; Viscosity | 2011 |
Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Atenolol; Cardiovascular Agents; Chlorthalidone; Combined Modality Therapy; Decontamination; Drug Overdose; Emergency Service, Hospital; Endoscopy, Digestive System; Extracorporeal Membrane Oxygenation; Female; Humans; Lisinopril; Multiple Organ Failure; Renal Dialysis; Shock, Cardiogenic; Tablets; Transcutaneous Electric Nerve Stimulation; Treatment Outcome | 2015 |
Molecular interaction of some cardiovascular drugs with human serum albumin at physiological-like conditions: A new approach.
Topics: Amiodarone; Atenolol; Captopril; Cardiovascular Agents; Humans; Hydrophobic and Hydrophilic Interactions; Propranolol; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Static Electricity; Timolol | 2018 |
Using a high-throughput zebrafish embryo screening approach to support environmental hazard ranking for cardiovascular agents.
Topics: Animals; Atenolol; Cardiovascular Agents; Ecotoxicology; Embryo, Nonmammalian; Metoprolol; Risk Assessment; Water Pollutants, Chemical; Zebrafish | 2020 |
Ultraviolet photolysis of four typical cardiovascular drugs: mechanisms, influencing factors, degradation pathways, and toxicity trends.
Topics: Atenolol; Atorvastatin; Bezafibrate; Cardiovascular Agents; Humic Substances; Kinetics; Metoprolol; Photolysis; Ultraviolet Rays; Water Pollutants, Chemical | 2021 |
Utilizing quantitative dried blood spot analysis to objectively assess adherence to cardiovascular pharmacotherapy among patients at Kenyatta National Hospital, Nairobi, Kenya.
Topics: Atenolol; Cardiovascular Agents; Cardiovascular Diseases; Dried Blood Spot Testing; Female; Hospitals; Humans; Kenya; Male; Medication Adherence | 2023 |